Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
08 May 2024 |
On P&L |
The Company releases the first three months 2024 financial results presentation
|
Download |
|
25 Apr 2024 |
On business and financial situation |
ROVI announces agreement to manufacture pre-filled syringes
|
Download |
|
27 Feb 2024 |
On P&L |
The Company releases the press release related to the full year 2023 financial results.
|
Download |
|
27 Feb 2024 |
On P&L |
The Company releases the full year 2023 financial results presentation.
|
Download |
|
27 Feb 2024 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
22 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 March and 21 March 2024
|
Download |
|
15 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 8 March and 14 March 2024
|
Download |
|
12 Mar 2024 |
On business and financial situation |
ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
|
Download |
|
08 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 1 March and 7 March 2024
|
Download |
|
07 Mar 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
08 Jan 2018 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted in the fourth quarter of 2017
|
Download |
|
21 Dec 2017 |
Préstamos, créditos y avales |
ROVI and the EIB agree to sign a loan to boost research into drug administration and prolonged-release technologies
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the press release related to the nine-month period ended 30 September 2017 results
|
Download |
|
08 Nov 2017 |
Información sobre Resultados |
ROVI releases the presentation related to the nine-month period ended 30 September 2017 results.
|
Download |
|
24 Oct 2017 |
Otros sobre negocio y situación financiera |
The Company releases the presentation related to the update of its Phase III-Prima 3 Risperidone ISM® project.
|
Download |
Pages
